Asarfi Hospital share news and announcements
BSE: 543943Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹179.50.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹335 Cr2,017th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 May 2026
- 20.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 11 May 2026
- 3.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 May 2026
- 18.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 11 May 2026
- 0.59
- Volume, BSEVolume. Shares traded on the last trading day.
- 27,000
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Asarfi Hospital half-yearly results
The board met on 7 Aug 2026 to consider quarterly results
Notice filed 4 Aug 2026
Asarfi Hospital annual reports, presentations and earnings calls
The company's own documents, latest first.Asarfi Hospital financials, year by year
Annual reports4
Investor presentations8
- We hereby submit the Investor Presentation for the Qtr ended 30th June 2026. (opens in a new tab)7 Aug 2026
- Investor Presentation of Asarfi Hospital Limited for the Quarter and Financial Year ended 31st March, 2026. (opens in a new tab)11 May 2026
- We Submission the Investor Presentation of the Company for the quarter ended December 31,2025. (opens in a new tab)9 Feb 2026
- Investor Presentation for Q2 & H1 OF FY 2025-26. (opens in a new tab)10 Nov 2025
- Investor Presentation for Q1 FY26 (opens in a new tab)7 Aug 2025
3 earlier presentations
- We here present the Investor Presentation of the company for the quarter and year ended March 31, 2025. (opens in a new tab)9 May 2025
- We wish to inform you that please find the attached hererwith the Investor Presentation of the Company for the quarter ended December'2024. (opens in a new tab)31 Jan 2025
- We herewith submitting the Investor Presentation for the Half Year ended Sept 30'2024. (opens in a new tab)30 Oct 2024
Earnings calls4
- We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year .... (opens in a new tab)30 May 2026
- We hereby submit the transcript of the Earning Conference call held on November 19, 2025, wherein the Unaudited Standalone & Consolidated financial Results for the half year ended September .... (opens in a new tab)22 Nov 2025
- We are enclosing herewith trasncript of earning conference call held on May12, 2025, wherein Audited standalone & Consolidated Financial result for the 2nd half year ended March 31, 2025 .... (opens in a new tab)14 May 2025
- We are enclosing herewith transcript of earning call held on November 06, 2024, wherein Unaudited Standalone & Consolidated Finnacial Results for the half year ended September 30, 2024 .... (opens in a new tab)9 Nov 2024
Asarfi Hospital share news and announcements
124 announcements, routine notices left out, newest first. Page 1 of 3.
Oct 2026
Sep 2026
Aug 2026
19 Aug · Board meeting
Meeting on 25 Aug 2026: annual general meeting4 Aug · Board meeting
Meeting on 7 Aug 2026: quarterly results
Jul 2026
Jun 2026
May 2026
5 May · Board meeting
Meeting on 11 May 2026: audited results
Feb 2026
2 Feb · Board meeting
Meeting on 9 Feb 2026: quarterly results
Dec 2025
Nov 2025
17 Nov · Intimation Of Material Event - Grant Of Accreditation
Oct 2025
Sep 2025
25 Sep · Board meeting
Meeting on 25 Sep 202520 Sep · Disclosure Regarding Clerical Error In Debtors' Ageing Statement In The Financial Statements For The Year Ended March 31, 2025
Aug 2025
12 Aug · Board meeting
Meeting on 20 Aug 2025: annual general meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 9 Oct 2026Credit ratingup 0.40%−0.8 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−9.5 pts vs Nifty 500) · volume 0.9× usual · The announcement (opens in a new tab)
- 14 Oct 2025Credit ratingup 2.60%+3.1 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+6.4 pts vs Nifty 500) · volume 6.7× usual · The announcement (opens in a new tab)
- 4 Mar 2025Board or managers changeddown 1.99%−2.1 pts vs Nifty 500market median 0.0% · five sessions −11.2% (−13.1 pts vs Nifty 500) · volume 0.2× usual · The announcement (opens in a new tab)
- 10 Sep 2024Credit ratingup 1.62%+1.0 pts vs Nifty 500market median 0.0% · five sessions +0.9% (−1.1 pts vs Nifty 500) · volume 0.3× usual · The announcement (opens in a new tab)
- 14 Aug 2023Board or managers changeddown 5.73%−5.5 pts vs Nifty 500market median 0.0% · five sessions +8.8% (+8.9 pts vs Nifty 500) · The announcement (opens in a new tab)
- 11 Aug 2023Board or managers changeddown 3.23%−2.8 pts vs Nifty 500market median 0.0% · five sessions −6.2% (−5.1 pts vs Nifty 500) · The announcement (opens in a new tab)
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Cash at the end of the period | At Mar 2024 | Consolidated | 0.70 | 0.70 | 0.0% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Adjustments from profit to cash | Year to Mar 2024 | Consolidated | 20.01 | 20.71 | +3.5% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Cash from investing | Year to Mar 2024 | Consolidated | −63.09 | −63.09 | 0.0% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Net change in cash, before currency effects | Year to Mar 2024 | Consolidated | −0.61 | −0.61 | 0.0% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Net change in cash | Year to Mar 2024 | Consolidated | −0.61 | −0.61 | 0.0% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Change in other current assets | Year to Mar 2024 | Consolidated | −0.06 | 1.43 | +2,563.9% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Cash generated before tax | Year to Mar 2024 | Consolidated | 26.25 | 26.95 | +2.7% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Cash from operations | Year to Mar 2024 | Consolidated | 26.07 | 26.07 | 0.0% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Other cash from investing | Year to Mar 2024 | Consolidated | −0.38 | −10.07 | −2,519.0% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |
| Adjustments from profit to cash | Year to Mar 2024 | Standalone | 19.80 | 20.50 | +3.6% | 5 Jul 2024 (opens in a new tab) | 27 Jul 2024 (opens in a new tab) |